Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American Society for Radiation Oncology

Practical Radiation Oncology

Volumn 1, Issue 4, 2011, Pages 218-223

  Nag, Subir ^a   Demanes, D Jeffrey ^b   Hagan, Michael ^c   Rivard, Mark J ^d   Thomadsen, Bruce R ^e   Welsh, James S ^f   Williamson, Jeffrey F ^c  

^a Northern California Kaiser Permanente ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; IMAGE ANALYSIS; IMPLANTED SOURCE STRENGTH; MALE GENITAL TRACT PARAMETERS; MEDICAL EVENT; PATIENT SAFETY; PERMANENT PROSTATE BRACHYTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CONTOURING; PROSTATE GLAND VOLUME; PROSTATE SEED IMPLANT MIGRATION; RADIATION DOSE; RADIATION HAZARD; RADIATION RELATED PHENOMENA; RADIATION SAFETY; TREATMENT PLANNING; TUMOR VOLUME;

EID: 80053587122     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2011.05.001     Document Type: Article

References (12)

1. Nath R., Bice W.S., Butler W.M., et al. AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137. Med Phys 2009, 36:5310-5322.
2. Tanaka O., Hayashi S., Matsuo M., et al. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion. Int J Radiat Oncol Biol Phys 2007, 69:614-618.
3. Kucway R., Vicini F., Huang R., Stromberg J., Gonzalez J., Martinez A. Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy. J Urol 2002, 167:2443-2447.
4. McLaughlin P.W., Evans C., Feng M., Narayana V. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys 2010, 76:369-378.
5. Hoffelt S.C., Marshall L.M., Garzotto M., Hung A., Holland J., Beer T.M. A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer. Int J Radiat Oncol Biol Phys 2003, 57:29-32.
6. Crook J., Milosevic M., Catton P., et al. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy 2002, 1:66-73.
7. Lee W.R., Roach M., Michalski J., Moran B., Beyer D. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy. Int J Radiat Oncol Biol Phys 2002, 54:457-461.
8. Gao M., Wang J.Z., Nag S., Gupta N. Effects of seed migration on post-implant dosimetry of prostate brachytherapy. Med Phys 2007, 34:471-480.
9. Nag S., Beyer D., Friedland J., Grimm P., Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 44:789-799.
10. Nag S., Bice W., DeWyngaert K., Prestidge B., Stock R., Yu Y. The American Brachytherapy Society recommendations for permanent prostate brachytherapy post-implant dosimetric analysis. Int J Radiat Oncol Biol Phys 2000, 46:221-230.
11. Rivard M.J., Coursey B.M., DeWerd L.A., et al. Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004, 31:633-674.
12. Hagan M.P., Saleh H., Moore M., Williamson J. Regulatory evaluation of prostate volume implants: pitfalls of a retrospective assessment. Brachytherapy 2011 Feb 23, [Epub ahead of print].